Hyperleptinemia is associated with impaired pulmonary host defense

JCI Insight

Volumn 1, Issue 8, 2016, Pages

  Ubags, Niki D J ^a,b   Stapleton, Renee D ^b   Vernooy, Juanita H J ^a   Burg, Elianne ^b   Bement, Jenna ^b   Hayes, Catherine M ^b   Ventrone, Sebastian ^b   Zabeau, Lennart ^c   Tavernier, Jan ^c   Poynter, Matthew E ^b   Parsons, Polly E ^b   Dixon, Anne E ^b   Wargo, Matthew J ^b   Littenberg, Benjamin ^b   Wouters, Emiel F M ^a   Suratt, Benjamin T ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988969910     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.82101     Document Type: Article

References (66)

1. Xu JQ, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. In: National Vital Statistics Reports. Vol. 64, No. 2. Hyattsville, Maryland, USA: National Center for Health Statistics; 2016.
2. Broulette J, Yu H, Pyenson B, Iwasaki K, Sato R. The incidence rate and economic burden of community-acquired pneumonia in a working-age population. Am Health Drug Benefits. 2013;6(8):494–503.
3. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281(1):61–66.
4. Almirall J, et al. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J. 2008;31(6):1274–1284.
5. Fine MJ, et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA. 1996;275(2):134–141.
6. Mertz D, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061.
7. Almirall J, Gonzalez CA, Balanzo X, Bolibar I. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest. 1999;116(2):375–379.
8. Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med. 2000;160(20):3082–3088.
9. Samokhvalov AV, Irving HM, Rehm J. Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis. Epidemiol Infect. 2010;138(12):1789–1795.
10. Fezeu L, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev. 2011;12(8):653–659.
11. Phung DT, Wang Z, Rutherford S, Huang C, Chu C. Body mass index and risk of pneumonia: a systematic review and meta-analysis. Obes Rev. 2013;14(10):839–857.
12. Corrales-Medina VF, Valayam J, Serpa JA, Rueda AM, Musher DM. The obesity paradox in community-acquired bacterial pneumonia. Int J Infect Dis. 2011;15(1):e54–e57.
13. Singanayagam A, Singanayagam A, Chalmers JD. Obesity is associated with improved survival in community-acquired pneumonia. Eur Respir J. 2013;42(1):180–187.
14. Easterbrook JD, et al. Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus. Influenza Other Respir Viruses. 2011;5(6):418–425.
15. Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr. 2007;137(5):1236–1243.
16. Conge GA, Gouache P, Joyeux Y, Goichot J, Fournier JM. Influence of different types of experimental obesity on resistance of the mouse to infection by Salmonella typhimurium and Klebsiella pneumoniae. Ann Nutr Metab. 1988;32(3):113–120.
17. Ubags ND, et al. The role of leptin in the development of pulmonary neutrophilia in infection and acute lung injury. Crit Care Med. 2014;42(2):e143–1e51.
18. + memory T cells. J Nutr. 2010;140(9):1691–1697.
19. Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol. 2010;184(6):3127–3133.
20. Paich HA, et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring). 2013;21(11):2377–2386.
21. + T-cell responses in diet-induced obese mice infected with influenza virus. Immunology. 2009;126(2):268–279.
22. Stapleton RD, Dixon AE, Parsons PE, Ware LB, Suratt BT, Network NARDS. The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest. 2010;138(3):568–577.
23. Kordonowy LL, et al. Obesity is associated with neutrophil dysfunction and attenuation of murine acute lung injury. Am J Respir Cell Mol Biol. 2012;47(1):120–127.
24. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69(1):29–35.
25. Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. Sepsis-induced immunosuppression: from bad to worse. Immunol Res. 2001;24(3):273–287.
26. Sideleva O, et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med. 2012;186(7):598–605.
27. Sinha MK, et al. Evidence of free and bound leptin in human circulation. J Clin Invest. 1996;98(6):1277–1282.
28. Valdez R, Narayan KM, Geiss LS, Engelgau MM. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. Am J Public Health. 1999;89(11):1715–1721.
29. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001;120(6):1883–1887.
30. Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab. 2004;89(6):2750–2755.
31. Castellano Filho DS, et al. Body weight gain and serum leptin levels of non-overweight and overweight/obese pregnant women. Med Sci Monit. 2013;19:1043–1049.
32. Huang KC, et al. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents. Int J Obes (Lond). 2004;28(4):470–475.
33. Menon V, et al. Factors associated with serum leptin in patients with chronic kidney disease. Clin Nephrol. 2004;61(3):163–169.
34. Molvarec A, et al. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol. 2011;9:124.
35. Nordfors L, Lonnqvist F, Heimburger O, Danielsson A, Schalling M, Stenvinkel P. Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int. 1998;54(4):1267–1275.
36. Schubring C, et al. Longitudinal analysis of maternal serum leptin levels during pregnancy, at birth and up to six weeks after birth: relation to body mass index, skinfolds, sex steroids and umbilical cord blood leptin levels. Horm Res. 1998;50(5):276–283.
37. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003;149(4):331–335.
38. Beberashvili I, et al. Longitudinal study of leptin levels in chronic hemodialysis patients. Nutr J. 2011;10:68.
39. Almirall J, Bolibar I, Balanzo X, Gonzalez CA. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J. 1999;13(2):349–355.
40. Brower RG, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327–336.
41. Oral EA, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346(8):570–578.
42. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol. 2002;168(8):4018–4024.
43. Milner JJ, Sheridan PA, Karlsson EA, Schultz-Cherry S, Shi Q, Beck MA. Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection. J Immunol. 2013;191(5):2474–2485.
44. Stapleton RD, Suratt BT. Obesity and nutrition in acute respiratory distress syndrome. Clin Chest Med. 2014;35(4):655–671.
45. Gong MN, Bajwa EK, Thompson BT, Christiani DC. Body mass index is associated with the development of acute respiratory distress syndrome. Thorax. 2010;65(1):44–50.
46. Martino JL, et al. Extreme obesity and outcomes in critically ill patients. Chest. 2011;140(5):1198–1206.
47. Hsu A, Aronoff DM, Phipps J, Goel D, Mancuso P. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Clin Exp Immunol. 2007;150(2):332–339.
48. La Cava A, Matarese G. The weight of leptin in immunity. Immunology. 2004;4(5):371–379.
49. Dixit VD, Mielenz M, Taub DD, Parvizi N. Leptin induces growth hormone secretion from peripheral blood mononuclear cells via a protein kinase C- and nitric oxide-dependent mechanism. Endocrinology. 2003;144(12):5595–5603.
50. Zarkesh-Esfahani H, et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol. 2001;167(8):4593–4599.
51. Caldefie-Chezet F, Poulin A, Vasson MP. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic Res. 2003;37(8):809–814.
52. Bruno A, Conus S, Schmid I, Simon HU. Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J Immunol. 2005;174(12):8090–8096.
53. Bellmeyer A, Martino JM, Chandel NS, Scott Budinger GR, Dean DA, Mutlu GM. Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am J Respir Crit Care Med. 2007;175(6):587–594.
54. Jain M, et al. Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-gamma. Am J Respir Crit Care Med. 2011;183(11):1490–1498.
55. Torpy DJ, Bornstein SR, Chrousos GP. Leptin and interleukin-6 in sepsis. Horm Metab Res. 1998;30(12):726–729.
56. Ubags ND, et al. A comparative study of lung host defense in murine obesity models: insights into neutrophil function [published online ahead of print April 29, 2016]. Am J Respir Cell Mol Biol. doi: 10.1165/rcmb.2016-0042OC.
57. Hunt WR, et al. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes. Am J Physiol Lung Cell Mol Physiol. 2014;306(1):L43–L49.
58. Madenspacher JH, et al. Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes. J Immunol. 2010;185(3):1660–1669.
59. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
60. Bernard, G.R., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med.1994;149(3 pt 1):818–824.
61. Eisner MD, et al. Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;164(2):231–236.
62. Vernooy JH, et al. Leptin modulates innate and adaptive immune cell recruitment after cigarette smoke exposure in mice. J Immunol. 2010;184(12):7169–7177.
63. Wargo MJ, et al. Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. Am J Respir Crit Care Med. 2011;184(3):345–354.
64. Palvinskaya T, et al. Effects of acute and chronic low density lipoprotein exposure on neutrophil function. Pulm Pharmacol Ther. 2013;26(4):405–411.
65. Suratt BT, Young SK, Lieber J, Nick JA, Henson PM, Worthen GS. Neutrophil maturation and activation determine anatomic site of clearance from circulation. Am J Physiol Lung Cell Mol Physiol. 2001;281(4):L913–L921.
66. Petty JM, et al. Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol. 2007;178(12):8148–8157.